Flagship KRAS mutant cancers are pancreatic, colorectal, lung, and urogenital adenocarcinomas [3]. It is known that approximately 30-50% of colorectal tumors have a mutated KRAS gene and approximately 5-10% of cases have a mutated BRAF gene [4]. Here, KRAS is linked to cancer.